Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Octreotide scanning for carcinoid tumours.

Literature DB >> 9338023

Octreotide scanning for carcinoid tumours.

Abstract

The somatostatin analogue octreotide may be used in the diagnosis of carcinoid and other neuroendocrine tumours. Radionuclide scanning following intravenous injection of 111Indium-labelled octreotide (111In-DTPA-pentetreotide) provides a sensitive, non-invasive method of localising somatostatin-positive tumours. The technique may also be used to identify patients who may respond to 'cold' octreotide therapy and to monitor therapeutic efficacy.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1997 PMID： 9338023 PMCID： PMC2431390 DOI： 10.1136/pgmj.73.861.399

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

11 in total

1. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991.

Authors:
Journal: J Nucl Biol Med Date: 1991 Oct-Dec

Review 2. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

Authors: J C Reubi
Journal: J Nucl Med Date: 1995-10 Impact factor: 10.057

Review 3. A ticket to ride: peptide radiopharmaceuticals.

Authors: A J Fischman; J W Babich; H W Strauss
Journal: J Nucl Med Date: 1993-12 Impact factor: 10.057

4. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.

Authors: E P Krenning; W H Bakker; W A Breeman; J W Koper; P P Kooij; L Ausema; J S Lameris; J C Reubi; S W Lamberts
Journal: Lancet Date: 1989-02-04 Impact factor: 79.321

5. Somatostatin analogue scintigraphy in carcinoid tumours.

Authors: D J Kwekkeboom; E P Krenning; W H Bakker; H Y Oei; P P Kooij; S W Lamberts
Journal: Eur J Nucl Med Date: 1993-04

Review 6. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors: E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal: Eur J Nucl Med Date: 1993-08

7. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Authors: E P Krenning; W H Bakker; P P Kooij; W A Breeman; H Y Oei; M de Jong; J C Reubi; T J Visser; C Bruns; D J Kwekkeboom
Journal: J Nucl Med Date: 1992-05 Impact factor: 10.057

Review 8. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors: C A Hoefnagel
Journal: Eur J Nucl Med Date: 1994-06

9. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection.

Authors: H Ahlman; B Wängberg; L E Tisell; O Nilsson; M Fjälling; E Forssell-Aronsson
Journal: Br J Surg Date: 1994-08 Impact factor: 6.939

10. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors.

Authors: L K Kvols
Journal: Gastroenterology Date: 1993-12 Impact factor: 22.682

6 in total

Octreotide scanning for carcinoid tumours.

1. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991.

Review 2. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

Review 3. A ticket to ride: peptide radiopharmaceuticals.

4. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.

5. Somatostatin analogue scintigraphy in carcinoid tumours.

Review 6. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

7. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Review 8. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

9. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection.

10. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors.

1. Alpha-fetoprotein Secreting Neuroendocrine Carcinoma of the Liver: a Case Report and Literature Review.

2. Utility of indium-111 octreotide to identify a cardiac metastasis of a carcinoid neoplasm.

3. Metal-bound claMP Tag inhibits proteolytic cleavage.

4. Primary hepatic neuroendocrine tumour masquerading as a giant haemangioma: an unusual presentation of a rare disease.

5. Diagnostic imaging of primary hepatic neuroendocrine tumors: a case and discussion of the literature.

6. (18)F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor.